Kynam Capital Management, LP Celldex Therapeutics, Inc. Transaction History

Kynam Capital Management, LP

$837 Million
Q2 2025

A detailed history of Kynam Capital Management, LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 6,100,729 shares of CLDX stock, worth $145 Million. This represents 14.83% of its overall portfolio holdings.

Number of Shares

6,100,729

Previous 6,500,000 6.14%

Holding current value

$145 Million

Previous $118 Million 5.23%

% of portfolio

14.83%

Previous 9.94%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$15.13 - $21.65 $6.04 Million - $8.64 Million	-399,271 Reduced 6.14%	6,100,729 $124 Million
Q1 2025 May 15, 2025	BUY	$18.15 - $27.6 $26.1 Million - $39.6 Million	1,435,793 Added 28.35%	6,500,000 $118 Million
Q4 2024 Feb 14, 2025	BUY	$23.31 - $32.4 $37.4 Million - $52 Million	1,605,598 Added 46.42%	5,064,207 $128 Million
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $2.23 Million - $3.1 Million	69,642 Added 2.05%	3,458,609 $117 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $16 Million - $20.8 Million	488,967 Added 16.86%	3,388,967 $125 Million
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $3.73 Million - $5.49 Million	-105,904 Reduced 3.52%	2,900,000 $122 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $4.39 Million - $7.89 Million	-194,096 Reduced 6.07%	3,005,904 $119 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $15.3 Million - $22.5 Million	600,000 Added 23.08%	3,200,000 $88.1 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $36.1 Million - $45.6 Million	1,190,549 Added 84.47%	2,600,000 $88.2 Million
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $6.81 Million - $9.29 Million	-195,939 Reduced 12.21%	1,409,451 $50.7 Million
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $146,206 - $238,834	5,263 Added 0.33%	1,605,390 $71.6 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $10.6 Million - $17.6 Million	467,868 Added 41.32%	1,600,127 $45 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $7.77 Million - $14.2 Million	379,225 Added 50.36%	1,132,259 $30.5 Million
Q1 2022 May 13, 2022	BUY	$27.64 - $39.32 $14.5 Million - $20.7 Million	526,308 Added 232.13%	753,034 $25.6 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $8.09 Million - $12.8 Million	226,726 New	226,726 $8.76 Million

Others Institutions Holding CLDX

# of Institutions

198

Shares Held

68.2M

Call Options Held

219K

Put Options Held

238K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.11B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Account

Kynam Capital Management, LP Celldex Therapeutics, Inc. Transaction History